136 related articles for article (PubMed ID: 22439687)
1. Green amorphous nanoplex as a new supersaturating drug delivery system.
Cheow WS; Hadinoto K
Langmuir; 2012 Apr; 28(15):6265-75. PubMed ID: 22439687
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled amorphous drug-polyelectrolyte nanoparticle complex with enhanced dissolution rate and saturation solubility.
Cheow WS; Hadinoto K
J Colloid Interface Sci; 2012 Feb; 367(1):518-26. PubMed ID: 22051687
[TBL] [Abstract][Full Text] [Related]
3. Green preparation of antibiotic nanoparticle complex as potential anti-biofilm therapeutics via self-assembly amphiphile-polyelectrolyte complexation with dextran sulfate.
Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2012 Apr; 92():55-63. PubMed ID: 22154010
[TBL] [Abstract][Full Text] [Related]
4. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation.
Nguyen MH; Yu H; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159
[TBL] [Abstract][Full Text] [Related]
5. Amorphous nanoparticle complex of perphenazine and dextran sulfate as a new solubility enhancement strategy of antipsychotic perphenazine.
Dong B; Hadinoto K
Drug Dev Ind Pharm; 2017 Jun; 43(6):996-1002. PubMed ID: 28121189
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the stability of amorphous drug-polyelectrolyte nanoparticle complex using a secondary small-molecule drug as the stabilizer: A case study of ibuprofen-stabilized curcumin-chitosan nanoplex.
Lim LM; Hadinoto K
Int J Pharm; 2020 Feb; 575():119007. PubMed ID: 31893545
[TBL] [Abstract][Full Text] [Related]
7. Carboxymethyl cellulose is a superior polyanion to dextran sulfate in stabilizing and enhancing the solubility of amorphous drug-polyelectrolyte nanoparticle complex.
Dong B; Hadinoto K
Int J Biol Macromol; 2019 Oct; 139():500-508. PubMed ID: 31386874
[TBL] [Abstract][Full Text] [Related]
8. A new bioavailability enhancement strategy of curcumin via self-assembly nano-complexation of curcumin and bovine serum albumin.
Yu H; Nguyen MH; Cheow WS; Hadinoto K
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():25-33. PubMed ID: 28415461
[TBL] [Abstract][Full Text] [Related]
9. Proof-of-concept preparation and characterization of dual-drug amorphous nanoparticle complex as fixed-dose combination of poorly soluble drugs.
Yu H; Ming Lim L; Dong B; Hadinoto K
Drug Dev Ind Pharm; 2019 Jan; 45(1):105-116. PubMed ID: 30196726
[TBL] [Abstract][Full Text] [Related]
10. Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin.
Lim LM; Tran TT; Long Wong JJ; Wang D; Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2018 Jul; 167():483-491. PubMed ID: 29727835
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP.
Dong B; Lim LM; Hadinoto K
Eur J Pharm Sci; 2019 Oct; 138():105035. PubMed ID: 31386892
[TBL] [Abstract][Full Text] [Related]
12. Benchmarking the Solubility Enhancement and Storage Stability of Amorphous Drug-Polyelectrolyte Nanoplex against Co-Amorphous Formulation of the Same Drug.
Lim LM; Park JW; Hadinoto K
Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631565
[TBL] [Abstract][Full Text] [Related]
13. Amorphization strategy affects the stability and supersaturation profile of amorphous drug nanoparticles.
Cheow WS; Kiew TY; Yang Y; Hadinoto K
Mol Pharm; 2014 May; 11(5):1611-20. PubMed ID: 24669821
[TBL] [Abstract][Full Text] [Related]
14. Millifluidic synthesis of amorphous drug-polysaccharide nanoparticle complex with tunable size intended for supersaturating drug delivery applications.
Tran TT; Nguyen MH; Tan YZ; Chew JW; Khan SA; Hadinoto K
Eur J Pharm Biopharm; 2017 Mar; 112():196-203. PubMed ID: 27903456
[TBL] [Abstract][Full Text] [Related]
15. Tailor-made release triggering from hot-melt extruded complexes of basic polyelectrolyte and poorly water-soluble drugs.
Kindermann C; Matthée K; Strohmeyer J; Sievert F; Breitkreutz J
Eur J Pharm Biopharm; 2011 Oct; 79(2):372-81. PubMed ID: 21596136
[TBL] [Abstract][Full Text] [Related]
16. A supersaturating delivery system of silibinin exhibiting high payload achieved by amorphous nano-complexation with chitosan.
Nguyen MH; Yu H; Dong B; Hadinoto K
Eur J Pharm Sci; 2016 Jun; 89():163-71. PubMed ID: 27140843
[TBL] [Abstract][Full Text] [Related]
17. A simple strategy to enhance the in vivo wound-healing activity of curcumin in the form of self-assembled nanoparticle complex of curcumin and oligochitosan.
Nguyen MH; Lee SE; Tran TT; Bui CB; Nguyen TH; Vu NB; Tran TT; Nguyen TH; Nguyen TT; Hadinoto K
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():54-64. PubMed ID: 30813056
[TBL] [Abstract][Full Text] [Related]
18. Controlling the burst release of amorphous drug-polysaccharide nanoparticle complex via crosslinking of the polysaccharide chains.
Nguyen MH; Tran TT; Hadinoto K
Eur J Pharm Biopharm; 2016 Jul; 104():156-63. PubMed ID: 27179586
[TBL] [Abstract][Full Text] [Related]
19. Enhanced dissolution performance of curcumin with the use of supersaturatable formulations.
Gosangari S; Dyakonov T
Pharm Dev Technol; 2013; 18(2):475-80. PubMed ID: 22881446
[TBL] [Abstract][Full Text] [Related]
20. Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs.
Cheow WS; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():314-21. PubMed ID: 26325060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]